These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1201 related items for PubMed ID: 15777975

  • 1. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF.
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [Abstract] [Full Text] [Related]

  • 2. Radiotherapy patterns of care study in lung carcinoma.
    Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J.
    J Clin Oncol; 2003 Dec 15; 21(24):4553-9. PubMed ID: 14597743
    [Abstract] [Full Text] [Related]

  • 3. [Evidence based chemotherapy for lung cancer].
    Watanabe H, Saijo N.
    Gan To Kagaku Ryoho; 2000 Jan 15; 27(1):30-43. PubMed ID: 10660731
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy and radiation in the nonoperative management of stage III non-small-cell lung cancer: the right chemotherapy works in the right setting.
    Green MR.
    Important Adv Oncol; 1993 Jan 15; ():125-37. PubMed ID: 8389320
    [Abstract] [Full Text] [Related]

  • 5. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 6. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.
    Ettinger DS.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):148-50. PubMed ID: 10210554
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
    Iranzo V, Bremnes RM, Almendros P, Gavilá J, Blasco A, Sirera R, Camps C.
    Lung Cancer; 2009 Jan 01; 63(1):63-7. PubMed ID: 18550204
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.
    Lung Cancer; 2007 Nov 20; 58(2):238-45. PubMed ID: 17658655
    [Abstract] [Full Text] [Related]

  • 10. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 20; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 11. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D, Bremer RH, Koppe F, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Pitz C, Simons J, ten Velde G, Dohmen J, Snoep G, Boersma L, Verschueren T, van Baardwijk A, Dehing C, Pijls M, Minken A, Lambin P.
    Radiother Oncol; 2006 Sep 20; 80(3):307-12. PubMed ID: 16949169
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P, Robinet G, Thomas P, Souquet PJ, Léna H, Vergnenégre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daurés JP, Mornex F, Pérol M, Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie.
    J Clin Oncol; 2005 Sep 01; 23(25):5910-7. PubMed ID: 16087956
    [Abstract] [Full Text] [Related]

  • 13. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan.
    Uno T, Sumi M, Ishihara Y, Numasaki H, Mitsumori M, Teshima T, Japanese PCS Working Subgroup of Lung Cancer.
    Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):414-9. PubMed ID: 18164865
    [Abstract] [Full Text] [Related]

  • 14. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 01; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 15. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):962-6. PubMed ID: 12899797
    [Abstract] [Full Text] [Related]

  • 16. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
    Jeremić B, Milicić B.
    Cancer; 2008 Feb 15; 112(4):876-84. PubMed ID: 18172901
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
    Dediu M, Horvat T, Tarlea A, Anghel R, Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C, Savu C.
    Lung Cancer; 2005 Jan 15; 47(1):93-101. PubMed ID: 15603859
    [Abstract] [Full Text] [Related]

  • 18. [Recent topics in chemotherapy for elderly patients with lung cancer].
    Okamoto H, Watanabe K.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1097-104. PubMed ID: 10945002
    [Abstract] [Full Text] [Related]

  • 19. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Jul 15; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP.
    Semin Oncol; 1999 Feb 15; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 61.